Other FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech BioPharma DiveThrough two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it s accrued.Read full story pharminent April 29, 2026 (Last updated: April 30, 2026) BioPharma Dive Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it s accrued. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Pfizer settles with generic drugmakers to protect blockbuster drug until 2031Next: Chiesi to buy KalVista in $1.9B deal for rare disease drug Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
